Blood test now reveals hidden shifts in brain gene activity

Rice University researchers have cracked a problem that's been limiting brain research for years: how to catch the subtle, fast changes in gene activity that traditional blood tests miss.

The challenge is real. Understanding when genes switch on and off in the brain is essential for diagnosing neurological disorders—but most current methods are either invasive (requiring direct brain access) or too blunt to detect small fluctuations. Scientists have been working with engineered proteins called released markers of activity, or RMAs, which brain cells produce and release into the bloodstream. The idea is elegant: measure the proteins in blood, no surgery needed.

But RMAs had a flaw. They lingered in the bloodstream for hours, creating a kind of background noise that masked the rapid changes researchers actually wanted to see. It's like trying to hear a whisper while someone's holding a steady tone in your ear.

The Rice team solved this by engineering RMAs that can be selectively erased. They designed the markers so that when an enzyme is injected into the bloodstream, it cuts the proteins apart, clearing roughly 90% of the background signal within 30 minutes. That reset gives researchers a clean slate to measure fresh gene-activity changes as they happen.

A Sharper Window Into Brain Function

In animal testing, this erasure method revealed gene-expression patterns that were previously invisible. Researchers could also repeat the process—inject the enzyme, watch the signal reset, measure the return of markers—to build a dynamic picture of how quickly gene activity changes over time.

"Using this enzyme, we separated the part that provides signal from the part that makes it last a long time in blood," explains Shirin Nouraein, a graduate student at Rice and lead author on the study. "We found a significant elevation in signal changes when we used these markers to track the dynamics of gene expression in the brain."

What makes this work matter beyond neurology is the principle underneath it. Jerzy Szablowski, assistant professor of bioengineering at Rice, frames it plainly: "The key advance here is a new way of thinking about serum markers—that we can modify them inside the bloodstream when we need to." That flexibility opens doors. The same erasable-marker concept could be adapted to detect tumors or lung disease through simple blood or urine tests, with no invasive procedures required.

The full study appears in Proceedings of the National Academy of Sciences. For now, this is still in animal testing, but the direction is clear: simpler, faster ways to read what's happening inside the body.